To further investigate the predicted aggressive phenotypic alterations observed, we also investigated the expression of specific EMT marker, such as: AKT1, AHNAK2, MUC1 and MUC5B, which were upregulated in both breast cancer cell lines (relative protein abundance levels in Supplementary Tables S6 and S7). This evidence concerns the gene AHNAK2 and breast cancer.